140 related articles for article (PubMed ID: 35355244)
1. A note on familywise error rate for a primary and secondary endpoint.
Proschan MA; Follmann DA
Biometrics; 2023 Jun; 79(2):1114-1118. PubMed ID: 35355244
[TBL] [Abstract][Full Text] [Related]
2. A gatekeeping procedure to test a primary and a secondary endpoint in a group sequential design with multiple interim looks.
Tamhane AC; Gou J; Jennison C; Mehta CR; Curto T
Biometrics; 2018 Mar; 74(1):40-48. PubMed ID: 28589692
[TBL] [Abstract][Full Text] [Related]
3. Adaptive extensions of a two-stage group sequential procedure for testing primary and secondary endpoints (II): sample size re-estimation.
Tamhane AC; Wu Y; Mehta CR
Stat Med; 2012 Aug; 31(19):2041-54. PubMed ID: 22733687
[TBL] [Abstract][Full Text] [Related]
4. Hierarchical testing of multiple endpoints in group-sequential trials.
Glimm E; Maurer W; Bretz F
Stat Med; 2010 Jan; 29(2):219-28. PubMed ID: 19827011
[TBL] [Abstract][Full Text] [Related]
5. Improved two-stage group sequential procedures for testing a secondary endpoint after the primary endpoint achieves significance.
Li H; Wang J; Luo X; Grechko J; Jennison C
Biom J; 2018 Sep; 60(5):893-902. PubMed ID: 29876964
[TBL] [Abstract][Full Text] [Related]
6. Testing a primary and a secondary endpoint in a group sequential design.
Tamhane AC; Mehta CR; Liu L
Biometrics; 2010 Dec; 66(4):1174-84. PubMed ID: 20337631
[TBL] [Abstract][Full Text] [Related]
7. Flexible selection of a single treatment incorporating short-term endpoint information in a phase II/III clinical trial.
Stallard N; Kunz CU; Todd S; Parsons N; Friede T
Stat Med; 2015 Oct; 34(23):3104-15. PubMed ID: 26112909
[TBL] [Abstract][Full Text] [Related]
8. Gatekeeping testing via adaptive alpha allocation.
Li JD; Mehrotra DV
Biom J; 2008 Oct; 50(5):704-15. PubMed ID: 18932133
[TBL] [Abstract][Full Text] [Related]
9. Familywise error control in multi-armed response-adaptive trials.
Robertson DS; Wason JMS
Biometrics; 2019 Sep; 75(3):885-894. PubMed ID: 30714095
[TBL] [Abstract][Full Text] [Related]
10. Adaptive extensions of a two-stage group sequential procedure for testing primary and secondary endpoints (I): unknown correlation between the endpoints.
Tamhane AC; Wu Y; Mehta CR
Stat Med; 2012 Aug; 31(19):2027-40. PubMed ID: 22729929
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous inference of a binary composite endpoint and its components.
Große Ruse M; Ritz C; Hothorn LA
J Biopharm Stat; 2017; 27(1):56-69. PubMed ID: 26881805
[TBL] [Abstract][Full Text] [Related]
12. Assessing the impact of efficacy stopping rules on the error rates under the multi-arm multi-stage framework.
Blenkinsop A; Parmar MK; Choodari-Oskooei B
Clin Trials; 2019 Apr; 16(2):132-141. PubMed ID: 30648428
[TBL] [Abstract][Full Text] [Related]
13. An efficient method for accommodating potentially underpowered primary endpoints.
Li J; Mehrotra DV
Stat Med; 2008 Nov; 27(26):5377-91. PubMed ID: 18759248
[TBL] [Abstract][Full Text] [Related]
14. Sample size determination with familywise control of both type I and type II errors in clinical trials.
Wang B; Ting N
J Biopharm Stat; 2016; 26(5):951-65. PubMed ID: 26881972
[TBL] [Abstract][Full Text] [Related]
15. An optimised multi-arm multi-stage clinical trial design for unknown variance.
Grayling MJ; Wason JMS; Mander AP
Contemp Clin Trials; 2018 Apr; 67():116-120. PubMed ID: 29474933
[TBL] [Abstract][Full Text] [Related]
16. Designing multi-arm multi-stage clinical trials using a risk-benefit criterion for treatment selection.
Jaki T; Hampson LV
Stat Med; 2016 Feb; 35(4):522-33. PubMed ID: 26456537
[TBL] [Abstract][Full Text] [Related]
17. Maximum type I error rate inflation from sample size reassessment when investigators are blind to treatment labels.
Żebrowska M; Posch M; Magirr D
Stat Med; 2016 May; 35(12):1972-84. PubMed ID: 26694878
[TBL] [Abstract][Full Text] [Related]
18. Statistical considerations for testing multiple endpoints in group sequential or adaptive clinical trials.
Hung HM; Wang SJ; O'Neill R
J Biopharm Stat; 2007; 17(6):1201-10. PubMed ID: 18027226
[TBL] [Abstract][Full Text] [Related]
19. Allocating recycled significance levels in group sequential procedures for multiple endpoints.
Xi D; Tamhane AC
Biom J; 2015 Jan; 57(1):90-107. PubMed ID: 25355702
[TBL] [Abstract][Full Text] [Related]
20. Clinical research and methodology: What usage and what hierarchical order for secondary endpoints?
Laporte S; Diviné M; Girault D;
Therapie; 2016 Feb; 71(1):27-41. PubMed ID: 27080628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
